Table of Contents
CHANGING PATTERN OF CAUSATIVE ORGANISMS
FACTORS RELATED TO THE INCREASING INCIDENCE OF
FUNGAL INFECTIONS
ASPERGILLOSIS
ASPERGILLOSIS AT AUTOPSY - RISK GROUPS Vogeser
et al Eur J Clin Microbiol Infect Dis 1999;18; 42-45
GROWTH OF ASPERGILLUS
COLONIZATION WITH CANDIDA SPECIES
HOSPITAL ACQUIRED CANDIDEMIA Wenzel Clin Infect
Dis 1995;20:1531-4
OCCURRENCE OF NOSOCOMIAL BLOODSTREAM INFECTIONS
Edmond et al , Clin Infect Dis 1999
INCIDENCE AND DISTRIBUTION OF NOSOCOMIAL BLOODSTREAM
INFECTIONS Edmond et al, Clin Infect Dis 1999
THERAPEUTIC STRATEGIES
PROPHYLAXIS WITH FLUCONAZOLE IN BONE MARROW TRANSPLANTATION
GOODMAN et al. N.ENGL.J.MED 1992, 326: 845
FLUCONAZOLE 400 mg/day AS PROPHYLAXIS IN BONE MARROW
TRANSPLANTATION SLAVIN et al. J. Infect. Dis. 1995;171:1545
FLUCONAZOLE versus PLACEBO AS PROPHYLAXIS IN NEUTROPENIA
Rotstein et al. Clin Infect Dis 1999;28:331
PROPHYLAXIS WITH FLUCONAZOLE IN ACUTE LEUKEMIA
WINSTON et al. Ann Intern Med 1993, 118: 495
FLUCONAZOLE 400 mg/day AS PROPHYLAXIS IN LIVER
TRANSPLANT RECIPIENTS WINSTON et al. Ann.Intern.Med. 1999;131:729-37
PREVENTION OF ASPERGILLOSIS
IMPACT OF NON-ORAL AMPHOTERICIN B ON THE PREVENTION
OF ASPERGILLUS INFECTIONS IN NEUTROPENIC PATIENTS
CHANGING INCIDENCE OF FUNGAL INFECTIONS IN BONE
MARROW TRANSPLANTATION O'DONNELL ET AL J.CLIN. ONCOL. 1994
RANDOMIZED STUDY OF AMPHOTERICIN B INHALATION FOR
THE PROPHYLAXIS OF FUNGAL INFECTIONS (Behre et al. Ann.Hematol. 1995 -
Germany)
ITRACONAZOLE VERSUS FLUCONAZOLE AS PROPHYLAXIS
DURING NEUTROPENIA MORGENSTERN et al, Brit J Haematol 1999
ITRACONAZOLE ORAL SOLUTION VERSUS PLACEBO AS PROPHYLAXIS
IN HEMATOLOGIC MALIGNANCY Menichetti et al.. Clin Infect Dis 1999;28:250
ITRACONAZOLE ORAL SOLUTION versus AMPHO-B CAPSULES
AS PROPHYLAXIS [HAROUSSEAU et al. Antimicrob Ag Chemother 2000; 44:1887-93]
DOUBLE-BLIND TRIAL ON ITRACONAZOLE AS PROPHYLAXIS
IN NEUTROPENIA [NUCCI et al. Clin Infect Dis 2000; 30:300]
DOCUMENTED FUNGAL INFECTIONS ITRACONAZOLE versus
PLACEBO
ALL RISK IS RELATIVE
GROUPS BENEFITTING FROM FLUCONAZOLE PROPHYLAXIS
IN NEUTROPENIA Rotstein et al. Clin Infect Dis 1999;28:331
COLONIZATION-BASED FLUCONAZOLE PROPHYLAXIS DURING
NEUTROPENIA Guiot et al, ICAAC 1996
AMBISOME versus FLUCONAZOLE plus ITRACONAZOLE as
PROPHYLAXIS Mattiuzzi et al. ICAAC 2000, Toronto. Abstr J 716, p.363
DISTRIBUTION OF SPECIES CAUSING CANDIDEMIA IN DUTCH
UNIVERSITY HOSPITALS VOSS ET AL. EUR J CLIN MICROBIOL INFECT DIS 1996
Empiric Therapy
AMPHOTERICIN-B FOR FEVER PERSISTING 4-7 DAYS
PERCEIVED NEED FOR PARENTERAL AMPHOTERICIN-B AFTER
PROPHYLAXIS IN NEUTROPENIC PATIENTS
INTERRELATION OF ANTIFUNGAL STRATEGIES DURING GRANULOCYTOPENIA
STATE OF THE ART??
AMBISOME® VERSUS AMPHOTERICIN-B AS EMPIRIC
THERAPY FOR REFRACTORY FEVER WALSH et al, N Engl J Med 1999;340:764
AMPHOTERICIN-B VERSUS ITRACONAZOLE iv --> solution
AS EMPIRIC THERAPY FOR REFRACTORY FEBRILE NEUTROPENIA Boogaerts: investigators
meeting ITR-INT-62 Janssen 1998
EMPIRICAL VORICONAZOLE vs AMBISOME FOR PERSISTENTLY
FEBRILE NEUTROPENICS II Walsh et al, ICAAC Toronto 2000. Abstr L1, Addendum
p. 20-21
DEFERVESCENCE AFTER EMPIRIC INSTITUTION OF ANTIFUNGALS
AMPHOTERICIN-B VERSUS FLUCONAZOLE AS EMPIRIC THERAPY
FOR REFRACTORY FEVER IN CANCER VISCOLI et al, EUR.J.CANCER 1996
EMPIRIC ANTIFUNGALS FOR REFRACTORY FEVER: DAY 3
versus DAY 6
DIAGNOSIS VERSUS EMPIRIC TREATMENT
WHAT DOES PRE-EMPTIVE MEAN?
IMPACT OF SYSTEMATIC CT-SCAN ON THE OUTCOME OF
PULMONARY ASPERGILLOSIS CAILLOT ET AL. J CLIN ONCOL 1997
ASPERGILLUS ANTIGEN FOR EARLIER DETECTION OF INVASIVE
INFECTION
PCR SCREENING FOR FUNGI IN HIGH RISK PATIENTS Hebart,
Einsele et al. Brit J Haematol 2000; 111:635-40
TIME TO POSITIVE TESTS TO DETECT PULMONARY ASPERGILLOSIS
Kami et al. Haematologica 2000; 85:745-52
START OF EMPIRIC ANTIFUNGALS
PRE-EMPTIVE ANTIFUNGALS: THE RATIONAL FUTURE?
GUIDELINES FOR THE TREATMENT OF CANDIDIASIS IDSA,
Clin Infect Dis 2000; 30:662-78
COMPARISON OF EFFICACY IN PROVEN AND PRESUMED FUNGAL
INFECTIONS
CANDIDA ISOLATES AND CANDIDEMIA IN BMT AFTER INTRODUCTION
OF FLUCONAZOLE PROPHYLAXIS (Marr, Seidel, White, Bowden J Infect Dis 2000:309)
HIGH DOSE FLUCONAZOLE RESCUE FOR REFRACTORY CANDIDA
INFECTIONS OUTCOME AS PER CANDIDA SPECIES
VORICONAZOLE FOR NON- ASPERGILLOSIS COMPANY FILE
DATA
CASPOFUNGIN FOR OROPHARYNGEAL CANDIDIASIS Randomized
Comparison of Response with Amphotericin B
EFFICACY IN PROVEN AND PROBABLE ASPERGILLUS INFECTIONS
PRIORITIES OF THE MEDICAL COMMUNITY
AMBISOME versus AMPHOTERICIN B in PROVEN AND PROBABLE
ASPERGILLOSIS DEMARIE, LEENDERS et al, Brit J Haematol. 1998
PREDICTABLE AMPHOTERICIN B NEPHROTOXITY WINGARD
et al. Clin. Infec.t Dis. 1999;29:1402-7
ITRACONAZOLE FOR ASPERGILLOSIS DENNING et al. Am
J Med 1994
PROBABLE AND PROVEN ASPERGILLOSIS: FAILURES AND
RESPONSES TO VORICONAZOLE
VORICONAZOLE FOR PROVEN AND PROBABLE ASPERGILLOSIS
- COMPANY FILE DATA
VORICONAZOLE FOR MOULD INFECTIONS RESPONSE BY SITE
OF INFECTION
PRE-EMPTIVE ANTIFUNGAL APPROACH |